
Jennifer B. Green, MD, and Dennis Bruemmer, MD, PhD, have a conversation on the rise of Type 2 diabetes worldwide, and the available and upcoming treatment options.

Jennifer B. Green, MD, and Dennis Bruemmer, MD, PhD, have a conversation on the rise of Type 2 diabetes worldwide, and the available and upcoming treatment options.

A panel of experts discuss the best ways to treat peripheral arterial disease after revascularization.

Expert rheumatologists work together to elucidate the current treatment paradigm for patients with systemic lupus erythematous or idiopathic inflammatory myopathies.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, discuss the management of atopic dermatitis with a focus on newer agents, including JAK inhibitors, currently in the drug approval pipeline.


Recommendations for properly treating pediatric and adult patients with inflammatory bowel disease based on common changes to the disease trajectory and it’s progressive nature.

James Januzzi, MD, and Javed Butler, MD, MPH, MBA, review recent updates in the recommendations for optimal medical care for patients with heart failure with reduced ejection fraction.















